07/11/2025
Pharmaline Partners with Tabuk Pharmaceuticals to Establish a Strategic Partnership in Saudi Arabia.
Values aligned, impact multiplied.
Frankfurt – October 2025
Pharmaline, a leading pharmaceutical manufacturer in Lebanon with EU Certified R&D and manufacturing site, and Tabuk Pharmaceuticals, a leading pharmaceutical company in the Kingdom of Saudi Arabia, have entered into a licensing and supply agreement to commercialize high -quality medicine in Saudi Arabia with a right to manufacture locally.
Today, we celebrate a partnership that goes far beyond business, one built on trust, shared purpose, and the belief that together, we can make a difference, together we serve our communities with excellence. United by scientific expertise, ambition, and a strong determination to push boundaries; Pharmaline and Tabuk are joining efforts to ensure access to quality medications with a deep commitment to patient well-being.
“We are proud to contribute to this vision and to play our part in enhancing bonds of the healthcare sector in the region,” said Dr. Carol Abi Karam, General Manager of Pharmaline. “As we look ahead, I am confident that today’s achievement is only the beginning of a long-lasting journey of collaboration and partnership in service towards patients and a continued commitment to Pharmaline’s mission of improving quality of life by providing medicines produced according to the highest quality standards. Together, Pharmaline and Tabuk are bound by trust and driven by impact.”
“We are pleased to partner with Pharmaline to further strengthen our efforts in enhancing access to high-quality medicines across the MENA region” said Dr. Ismail Shehadeh, CEO of Tabuk Pharmaceuticals. “Through such partnerships, we continue to deliver on our mission to improve patients’ lives and reinforce Tabuk’s leadership in providing trusted, affordable, and innovative healthcare solutions.”
